{"schema":"hottub-news/story/v1","story":"st_i4zwv4se55p2wb3ta4ja","title":"[國際] 諾貝爾獎週登場 減重藥物研究熱門角逐生醫獎","title_en":"Nobel Prize week arrives with weight loss drug research hot contender for medical prize","outlets":3,"brief":null,"page":"https://hottub.news/stories/nobel-prize-week-sees-weight-loss-drug-research-hot-contender-for-i4zwv4se55","count":3,"items":[{"id":"n_snkwnbsuik64asvl4cnq","seq":1760539,"kind":"article","title":"[國際] 諾貝爾獎週登場 減重藥物研究熱門角逐生醫獎","title_en":"Nobel Prize week arrives with weight loss drug research hot contender for medical prize","url":"https://www.rti.org.tw/news?pid=235724&uid=3","summary":"2026年諾貝爾獎週今天( 5日)登場，首先揭曉的諾貝爾醫學獎，以調節食慾的荷爾蒙相關研究呼聲最高，這些研究為「瘦瘦針」這類知名減重藥物奠定基礎。 法新社報導，諾貝爾醫學、物理、化學、文學、和平與經濟學等6大獎項，將從今天開始至10月12日陸續公布。 諾貝爾獎觀察人士告訴法新社，諾貝爾醫學獎預計在台灣時間今天下午5時30分公布，可能頒給為胰妥讚（Ozempic）、猛健樂（Mounjaro）等減重藥物奠定基礎的研究成果。 相關研究可能包括「微生物體」（Microbiome）研究，以及調節飽足感與飢餓感的瘦體素（leptin）和飢餓素（ghrelin）的發現；另一項則是「類升糖素胜肽-1」（GLP-1）研究，GLP-1是人體進食後由腸道分泌的荷爾蒙，會傳遞飽足訊號，胰妥讚等藥物的機轉正是模擬這種荷爾蒙的作用。 數據分析公司科睿唯安（Clarivate）研究分析主管潘道貝里（David Pendlebury）說：「上述任何一項研究獲得諾貝爾獎肯定的可能性都很高。」 科睿唯安主要根據論文被引用次數，來預測諾貝爾獎的潛在得主。…","published":"2026-10-05T04:10:00Z","seen":"2026-10-05T04:36:27Z","lang":"zh","country":"TW","source":{"id":"kite-rti-org-tw-c82119","name":"rti.org.tw","domain":"rti.org.tw","outlet":{"wikidata":"Q698884","name":"Radio Taiwan International","type":"broadcaster","country":"TW","designations":["international broadcasting","radio station"]}},"via":"kite-rti-org-tw-c82119","topics":["國際"],"authors":["author","新聞編輯"],"story":"st_i4zwv4se55p2wb3ta4ja","category":"health","category_p":0.6000000238418579,"sentiment":"neutral","tone":0.25999999046325684,"political":0.03999999910593033},{"id":"n_i4zwv4se55p2wb3ta4ja","seq":1759071,"kind":"article","title":"諾貝爾獎週登場 減重藥物研究熱門角逐生醫獎","title_en":"Nobel Prize week sees weight loss drug research hot contender for biomedical award","url":"https://tw.news.yahoo.com/%E8%AB%BE%E8%B2%9D%E7%88%BE%E7%8D%8E%E9%80%B1%E7%99%BB%E5%A0%B4-%E6%B8%9B%E9%87%8D%E8%97%A5%E7%89%A9%E7%A0%94%E7%A9%B6%E7%86%B1%E9%96%80%E8%A7%92%E9%80%90%E7%94%9F%E9%86%AB%E7%8D%8E-035450815.html","summary":"（中央社斯德哥爾摩5日綜合外電報導）2026年諾貝爾獎週今天登場，首先揭曉的諾貝爾醫學獎，以調節食慾的荷爾蒙相關研究呼聲最高，這些研究為「瘦瘦針」這類知名減重藥物奠定基礎。","published":"2026-10-05T03:54:50Z","seen":"2026-10-05T04:29:34Z","lang":"zh","country":"TW","source":{"id":"kite-tw-news-yahoo-com-ae7227","name":"tw.news.yahoo.com","domain":"tw.news.yahoo.com"},"via":"kite-tw-news-yahoo-com-ae7227","story":"st_i4zwv4se55p2wb3ta4ja","category":"health","category_p":0.6899999976158142,"sentiment":"neutral","tone":0.20000000298023224,"political":0.03999999910593033},{"id":"n_vkdvac6fdqius3phao7q","seq":1763772,"kind":"article","title":"諾貝爾獎週登場 減重藥物研究熱門角逐生醫獎","title_en":"Nobel Prize week arrives, weight loss drug research hot contender for biomedical award","url":"https://www.cna.com.tw/news/aopl/202610050075.aspx","summary":"（中央社斯德哥爾摩5日綜合外電報導）2026年諾貝爾獎週今天登場，首先揭曉的諾貝爾醫學獎，以調節食慾的荷爾蒙相關研究呼聲最高，這些研究為「瘦瘦針」這類知名減重藥物奠定基礎。","published":"2026-10-05T03:54:50Z","seen":"2026-10-05T05:04:23Z","lang":"zh","country":"TW","source":{"id":"kite-feedburner-com-093996","name":"feedburner.com","domain":"feeds.feedburner.com"},"via":"kite-feedburner-com-093996","entities":[{"id":"Q7191","name":"Nobel Prize","type":"event"}],"story":"st_i4zwv4se55p2wb3ta4ja","category":"health","category_p":0.6899999976158142,"sentiment":"neutral","tone":0.20000000298023224,"political":0.03999999910593033}]}